C4 Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.67

+0.32 (+7.36%)

As of Jun 30, 10:26 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +740.3% upside

Low Target $29.92

Average Target $39.24

High Target $50.68

Current Price $4.67

Current
$4.67

Target
$39.24

$29.92 $39.24 avg $50.68

Scenario Analysis

Bear Case

$29.92

540.7%

Low target

Base Case

$39.24

+740.3%

Avg target

Bull Case

$50.68

+985.2%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.60

1.6% from high

52-Week Low

$1.40

+234.8% from low

Target vs 52W High

$39.24

+753.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%